Home     About Us     Pipeline     Contact Us     Site Map      
Technical Information     Intellectual Property      
Publications
 
                            Indication                                        Articles
  

     CDIM 9                Breast Cancer                  http://breast-cancer-research.com/content/pdf/bcr1761.pdf

                                                                         /Documents/BreastCancResTreat-2007-in press.pdf

                                                                         http://mct.aacrjournals.org/cgi/reprint/3/3/247.pdf
                                   
                                   Colon Cancer                   http://mct.aacrjournals.org/cgi/reprint/5/5/1362
                                                                         http://molpharm.aspetjournals.org/cgi/content/abstract/68/6/1782
                                   
                                   Prostate Cancer               http://molpharm.aspetjournals.org/cgi/content/abstract/71/2/558?ck=nck  

                                  

                                   Endometrial Cancer          /Documents/MolCanc-2008-47-492.pdf

                                   

                                   Bladder Cancer                 http://cancerres.aacrjournals.org/cgi/reprint/66/1/412.pdf

                                  
                                   Renal Cancer                    /Documents/ClinCancRes-2007-13-6743.pdf
                                  
                                   Anti-inflammatory            /Documents/Vascular_research_2005.pdf
 
 
Indications and Additional Compounds
 
Breast Cancer               CDIM 1                            http://mct.aacrjournals.org/cgi/reprint/3/3/247.pdf
 

Colon Cancer                CDIM 1, 4                        http://mct.aacrjournals.org/cgi/reprint/5/5/1362

                                   CDIM 1, 4                        http://molpharm.aspetjournals.org/cgi/content/abstract/68/6/1782

                                   CDIM 2, 3                        http://mct.aacrjournals.org/cgi/reprint/5/9/2324

                                   CDIM 5, 7                        http://cancerres.aacrjournals.org/cgi/content/abstract/67/2/674
 
Pancreatic Cancer         CDIM 1, 5,  7                   http://www.jbc.org/cgi/reprint/280/26/24903

                                   CDIM 4                            /Documents/Carcinog-2006-27-717.pdf

 
Prostate Cancer            CDIM 1, 4                        http://molpharm.aspetjournals.org/cgi/content/abstract/71/2/558?ck=nck
 
Endometrial Cancer       CDIM 1, 4                        /Documents/MolCanc-2008-47-492.pdf
 
Bladder Cancer             CDIM 1, 4                         http://cancerres.aacrjournals.org/cgi/reprint/66/1/412.pdf                          
 
Renal Cancer                CDIM 1, 4                         /Documents/ClinCancRes-2007-13-6743.pdf    
 
Ovarian Cancer             CDIM 4                             http://mct.aacrjournals.org/cgi/content/abstract/5/9/2324

                                  

Acute Myelogenous        CDIM 4, 9, 14, 34             /cancerres.aacrjournals.org/cgi/content/abstract/65/7/2890

Leukemia                                                                                  

                                

Anti-inflammatory         CDIM 4                             /Documents/Vascular_research_2005.pdf  

                                                  Molecular_Pharmacology_Oct_2008.pdf